Objective. Recent evidence from genetic, cell biology, and animal model studies has suggested a pivotal role of autophagy in mediating systemic lupus erythematosus (SLE). However, the genetic basis has not yet been thoroughly examined. Therefore, the aim of the present study was to identify additional susceptibility variants in autophagy-related genes along with their functional significance.
1
Rong Mu, 3 Chun Li, 3 Jian-ping Guo, 3 Zhan-guo Li, 3 Geng Wang, 4 Hu-ji Xu, 4 Yan-jie Hao, 1 Zhuo-li Zhang, 1 Wei-hua Yue, 5 Huoru Zhang, 6 Ming-hui Zhao, 1 and Hong Zhang 1 Objective. Recent evidence from genetic, cell biology, and animal model studies has suggested a pivotal role of autophagy in mediating systemic lupus erythematosus (SLE). However, the genetic basis has not yet been thoroughly examined. Therefore, the aim of the present study was to identify additional susceptibility variants in autophagy-related genes along with their functional significance.
Methods. First, we performed a gene family-based genetic association analysis in SLE patients with the use of ImmunoChip arrays, and then we selected the most strongly associated polymorphisms for replication in additional cohorts. To identify regulatory clues, we analyzed publicly available blood expression quantitative trait locus data and Encyclopedia of DNA Elements data on transcription factor binding sites and cell typespecific differential expression. Functional effects were tested by luciferase reporter assays, electrophoretic mobility shift assays, and differential gene expression assays.
Results. In 14,474 samples, we observed that the rare Chinese variant rs933717T was associated with susceptibility to SLE (0.11% in cases versus 0.87% in controls; P = 2.36 3 10 -10 , odds ratio 0.13). The rs933717 risk allele C correlated with increased MAP1LC3B expression; increased MAP1LC3B messenger RNA was observed in SLE patients and in lupus-prone mice. In reporter gene constructs, the risk allele increased luciferase activity up to 2.7-3.8-fold in both HEK 293T and Jurkat cell lines, and the binding of HEK 293T and Jurkat cell nuclear extracts to the risk allele was also increased.
Conclusion. We observed a likely genetic association between light chain 3B, a widely used marker for autophagy, and susceptibility to SLE.
Systemic lupus erythematosus (SLE) is a complex autoimmune disease with diverse clinical phenotypes and outcomes (1) . Although the exact pathogenesis of SLE remains unclear, genetic factors are known to play key roles. To date, hypothesis-free genome-wide association studies (GWAS) have identified >80 susceptibility loci (2) . However, all of these variants account for no more than 30% of the total genetic risk in SLE, and our knowledge of the genetic background is still limited (2) . Further pathway testing analysis might help to improve our understanding of the pathogenic processes implicated in SLE.
Autophagy is an evolutionarily conserved homeostatic process by which cytoplasmic materials are delivered to lysosomes for degradation (3) . The autophagic process is implemented by autophagy-related proteins that also play a part in regulating immune responses, including the direct elimination of microorganisms, inflammation, antigen presentation, lymphocyte homeostasis, and secretion of immune mediators (4) . Recent studies suggest that autophagy is deregulated in peripheral T and B cells in lupus- prone mice and SLE patients (5) (6) (7) . Strikingly, the number of autophagosomes in CD19+ B cells from NZB/NZW mice increased significantly before the disease had developed (7) . In addition, more recent data indicated that a related process, light chain 3 (LC3)-associated phagocytosis, controlled immune responses to dying cells; its inhibition led to development of an SLE-like disease (8) (9) (10) . Inhibition of autophagy is likely to ameliorate murine lupus via reduction of proinflammatory cytokines. All of these studies suggest that autophagy plays a highly important role in SLE (11) . Thus, it would be useful to discover the extent to which disease-associated genetic variants in LC3-associated phagocytosis-related genes affect autophagy in humans.
Genetic data derived from GWAS and follow-up studies indicated variants in genes related to autophagy, including ATG5, ATG7, IRGM, DRAM1, CDKN1B, APOL1, MTMR3, CLEC16A, LRRK2, and ATG16L2, especially in Asian populations (12) (13) (14) (15) (16) (17) (18) (19) (20) . Most of these genetic associations (ATG5, ATG7, IRGM, MTMR3, LRRK2, and ATG16L2) could be replicated in our previous studies (2, 13, 14, 20) . However, only a few of these genetic associations were reported in Caucasians (ATG5, IRGM, and CLEC16A) or Africans (APOL1). This could suggest a genetic heterogeneity, and that the autophagy gene has a major genetic impact in Asian populations (18, 21) . Thus, there is a need for a systematic evaluation of genetic associations in SLE patients from a pathway perspective, especially in Asians. In addition, the question remains as to whether the associated variant might have functional significance.
To find additional autophagy gene variants in Chinese SLE patients, in the present study we included genes involved in the autophagic process according to the HGNC. We then conducted a genetic association study in >10,000 Han Chinese using a 4-stage strategy (Figure 1 ), including genetic discovery, genetic replication, bioinformatic analysis, and experimental validation.
PATIENTS AND METHODS
Sample description. The discovery cohort consisted of 500 healthy donors (mean AE SD age 32.0 AE 8.6 years; female: male ratio 3:1) and 500 SLE patients (Northern Han Chinese) (mean AE SD age 31.9 AE 11.2 years; female:male ratio 6:1). Replication cohort 1 consisted of 7,180 healthy donors (mean AE SD age 37.6 AE 15.3 years; female:male ratio 4:1) and 2,666 SLE patients (mean AE SD age 34.6 AE 13.4 years; female:male ratio 9:1) (all Northern Han Chinese). To further replicate our genetic finding, 1,366 SLE patients and 2,279 controls (replication cohort 2) were enrolled (all Southern Han Chinese). In all patients, SLE was diagnosed by local rheumatologists, and the diagnosis met the American College of Rheumatology revised criteria (22) as updated in 1997 (23 Genes and single-nucleotide polymorphism (SNP) selection. A total of 46 autophagy-related genes were found by searching the HGNC database (www.genenames.org). As shown in Figure 1 , 5 genes were excluded because they were pseudogenes (BECN1P1, ATG3P1, ATG12P1, ATG12P2, and ATG4AP1), and 9 genes were not covered by ImmunoChip (MAP1LC3C, ATG4B, SNX4, WIPI2, RB1CC1, ATG2A, DRAM1, ATG2B, and GABARAPL2). This left a total of 32 genes for further analysis: ATG4C, DRAM2, ATG9A, ATG16L1, ATG7, ATG3, ATG10, ATG12, ATG5, ATG9B, SNX30, AMBRA1, ATG13, ATG16L2, EI24, GABARAPL1, ATG101, MAP1LC3B2, ULK1, ATG14, MAP1LC3B, GABARAP, ULK2, BECN1, VMP1, WIPI1, EPG5, ATG4D, MAP1LC3A, SOGA1, ATG4A, and VMA21. SNPs in autophagy-related genes were included, along with a 20-kb segment upstream and a 20-kb segment downstream. The results for 6 genes (ATG9A, ATG3, ATG13, GABARAP, BECN1, and SOGA1) should be interpreted with caution due to single variant involvement in ImmunoChip (24) (Figure 1 ). We analyzed a total of 342 SNPs, mapped to 26 loci associated with autophagyrelated genes (>2 SNPs per gene).
Genotyping and quality control. During the discovery stage, 1,000 participants (500 SLE patients and 500 healthy controls) were genotyped using ImmunoChip, and quality control was undertaken as previously reported (24) . Of these, 10 SLE patients and 7 healthy controls were excluded due to a low call rate, relatedness, or the presence of outliers (Figure 1 ). During the replication stage, genotyping was performed by TaqMan allele discrimination assays (replication cohort 1) using a TaqMan Universal PCR Master Mix and a predesigned SNP genotyping assay mix. These mixes contained polymerase chain reaction (PCR) primers and probes purchased from Applied Biosystems. Genotyping was performed using a 7500 Sequence Detection System (Applied Biosystems), or genotype data were directly extracted from a HumanOmniZhongHua-8 BeadChip (replication cohort 2) (Huoru Zhang, et al: unpublished observations).
Bioinformatic analysis. Variants were annotated using Encyclopedia of DNA Elements (ENCODE) data and blood expression quantitative trait locus (eQTL) data. Regulatory features were annotated using the following databases: rVarBase (http://rv.psych.ac.cn), Ensemble (http://asia.ensembl. org/index.html), rSNPBase (http://rsnp.psych.ac.cn), SNiPA (http://snipa.helmholtz-muenchen.de/snipa/index.php), Regulome DB (http://regulome.stanford.edu), and HaploReg v4.1 (http:// archive.broadinstitute.org/mammals/haploreg). Genetic signatures of natural selection in the human genome were analyzed using the Human Genome Diversity Project Selection Browser (http://hgdp. uchicago.edu).
Allele-dependent gene expression regulations/eQTLs were queried using the Gene Expression Variation (GENE-VAR) database (http://www.sanger.ac.uk/humgen/genevar) and the Genome-Wide Repository of Associations between SNPs and Phenotypes database (https://grasp.nhlbi.nih.gov/overview. aspx). Differential messenger RNA (mRNA) expression data were obtained from ArrayExpress (http://www.ebi.ac.uk/arrayex press).
Luciferase reporter assay. Sequences of 101 bp flanking rs933717 were synthesized and subcloned into pGL4.23 (engineered firefly luciferase gene luc2/minimal promoter [luc2/minP]; Promega) using the Kpn I and Bgl II restriction sites (sequences are shown in Supplementary Flow chart of the study design. In stage 1, autophagy-related genes were systematically selected and a tentative genetic discovery study was conducted using ImmunoChip arrays. Stage 2 was performed to replicate in independent populations novel loci discovered in stage 1. After combined analysis with the discovery and replication 1 cohorts, single-nucleotide polymorphisms (SNPs) with significance at P < 2.6 9 10 À7 were further replicated using the replication 2 cohort. After the 2-stage genetic association analysis, bioinformatic analysis was performed to annotate the susceptibility loci in stage 3. Given the possible functional annotations for the novel loci from stage 3, in-house experimental validations were performed in vitro in stage 4. SLE = systemic lupus erythematosus; eQTL = expression quantitative trait locus; HGDP = Human Genome Diversity Project; EMSA = electrophoretic mobility shift assay; PBMC = peripheral blood mononuclear cell.
Electrophoretic mobility shift assay (EMSA). Nuclear proteins from HEK 293T and Jurkat cells were extracted using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific). EMSA was performed according to instructions for a DIG Gel Shift Kit (catalog no. 335 3591910; Roche). The single-stranded oligonucleotides used to synthesize the double-stranded ones are shown in Supplementary Table 2 , http://onlinelibrary.wiley.com/doi/10.1002/art. 40353/abstract. For supershift assays, 10 ll of anti-EBF-1 (catalog no. H00001879-D01P; Novus Biologicals), anti-ROAZ (catalog no. ab169096; Abcam), or anti-ZIC4 (catalog no. sc-101202; Santa Cruz Biotechnology) antibody was incubated with nuclear proteins from HEK 293T or Jurkat cells for 1 hour before adding the relevant labeled probe. Electrophoresis took place in 5% polyacrylamide gels (in 0.59 Tris-borate-EDTA [TBE] buffer), and the dye was run two-thirds of the way to the bottom of the plate in 0.59 TBE buffer at 50V. The gel was then transferred to nylon membranes (catalog no. LC2003; Thermo Fisher Scientific) at 200 mA for 30 minutes and crosslinked at 120 9 100 lJ/cm 2 . After incubation for 30 minutes in blocking solution, the membrane was incubated with antibody solution for 1 hour and washed twice in washing buffer for 15 minutes. The membrane was then exposed and scanned using an LAS-3000 Imaging System (GE Healthcare Bioscience). The experiments were carried out in triplicate.
LC3B-II Western blotting in MRL-lpr/lpr and C57BL mice. Lymph nodes from 10 MRL-lpr/lpr mice (mean AE SD weight 23.1 AE 0.8 gm) and 10 C57BL mice (mean AE SD weight 22.4 AE 0.9 gm) were obtained for Western blotting. The antibodies used were specific for b-actin (catalog no. 8457; Cell Signaling Technology) and LC3 (catalog no. L7543; Sigma-Aldrich). Tissue proteins from the inguinal lymph nodes were extracted and lysed in radioimmunoprecipitation assay buffer (100 mM Tris HCl [pH 8], 150 mM NaCl, 1% Triton X-100, 1 mM MgCl 2 , and 25 mM Na 3 VO 4 ) in the presence of complete protease inhibitor mixture (catalog no. P8340; Sigma-Aldrich). The proteins were separated by 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then transferred to a PVDF membrane (Millipore). The antibody dilutions were 1:1,000 for both anti-LC3 and anti-b-actin. The signal was detected using enhanced chemiluminescence detection reagents, and images were visualized using an LAS-3000 Imaging System. LC3B-II levels were normalized by densitometry to b-actin levels using ImageJ software (National Institutes of Health).
All mice were purchased from the Model Animal Research Center of Nanjing University and maintained in pathogenfree housing conditions. Assay procedures were performed according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals (Ministry of Health, People's Republic of China, 1998). The study was approved by the Ethics Committee of Peking University.
Statistical analysis. Allelic and genotypic associations were assessed using Plink (https://www.cog-genomics.org/plink) to give the odds ratio with a 95% confidence interval. Quantitative variables with a normal distribution were expressed as the mean AE SD, and Student's t-test was performed. In eQTL analysis, Spearman's coefficient was calculated. Statistical analysis was performed with SPSS 13.0 software.
RESULTS
Novel genetic associations of MAP1LC3B rs933717 in SLE. The discovery stage of the genetic analysis found 13 SNPs in 7 autophagy-related genes (ATG7, ATG16L1, ATG5, AMBRA1, EI24, WIPI1, and MAP1LC3B) with P < 0.05. Of these genes, ATG5 showed the most associations, consistent with previous reports on GWAS and candidate genes (12,13) (see Supplementary Table 3 , http://online library.wiley.com/doi/10.1002/art.40353/abstract).
Since the aim was to identify novel gene associations, we excluded ATG7, ATG5, and ATG16L1 from further study because they had been associated in our previous study (13) . We therefore studied 4 other SNPs in promising loci in an additional replication cohort (replication cohort 1). From these, we identified 2 novel loci that were significantly associated with SLE (P < 0.05); the strongest signal was from rs933717 of MAP1LC3B (P discovery = 7.57 9 10 -3 , P replication1 = 1.42 9 10 -8 ), which approached genome-wide significance (P < 5 9 10 -8 ) ( Table 1) . Therefore, rs933717 was replicated in a second independent cohort (P replication2 = 2.22 9 10
) and reached genome-wide significance when the cohorts were combined (P = 2.36 9 10 -10 ) ( Table 1) . Bioinformatic functional annotations of MAP1LC3B rs933717 eQTL analysis. MAP1LC3B rs933717 was annotated to be expression SNPs in ENCODE data, as it showed that rs933717CC (risk) correlated with increased MAP1LC3B expression (P = 6 9 10 ) (Figure 2B) , the Genotype-Tissue Expression pilot analysis (P = 1.55 9 10 -7 ) (25), and a genome-wide eQTL analysis in whole peripheral blood from 1,469 unrelated individuals (P = 9.7 9 10 -9 ) (26). In addition, risk genotypes of rs933717 correlated significantly with higher expression of several autophagy-related genes, suggesting trans-eQTL effects (see Supplementary Table 4 , http://onlinelibrary.wiley.com/doi/ 10.1002/art.40353/abstract). 3 and 4) . ROAZ-, EBF-1-, and ZIC4-specific antibodies were not observed to supershift the complex formation using either the C or T probe (lanes 7-12) . The digoxigenin-labeled C probe showed a higher affinity for nuclear protein-DNA complex (lanes 6, 8, 10, and 12). Lanes 1 and 2 were negative controls. SNP = single-nucleotide polymorphism.
Prediction of regulatory function. The in silico bioinformatic analysis with ENCODE data demonstrated that rs933717 resided in a transcription factor (TF) binding region. Four binding site motifs span the rs933717 region for binding by the following TFs: EBF_known1, Roaz_1, Roaz_2, and Zic_4. The differences between the logarithm of odds scores for the alleles T and C (risk) were 8.8, 11.9, 0.2, and 3.7 for EBF_known1, Roaz_1, Roaz_2, and Zic_4, respectively ( Figure 2C ). The data showed that rs933717 could affect transcriptional enhancer activity, suggesting that rs933717 might reside in an important region for gene transcriptional regulation (see Supplementary Tables  5-7 , http://onlinelibrary.wiley.com/doi/10.1002/art.40353/ abstract).
Genetic signatures of natural selection in the human genome. We further investigated the detailed global allele frequency distribution of rs933717 in 53 populations. Intriguingly, the risk allele rs933717C showed regional enrichment; the highest frequencies (~100%) were found in East Asia, South Asia, and Southeast Asia, followed by the Middle East and Europe, and the lowest were found in Africa ( Figure 2D ). Population selection analysis indicated that standardized integrated haplotype scores were 1.781 in Utah residents with ancestry from northern and western Europe (CEU) and 1.477 in Yoruba in Ibadan, Nigeria (YRI), and Fay and Wu's H+ was -13.663 in CEU and -3.449 in YRI. Neither the standardized integrated haplotype scores nor Fay and Wu's H+ were available in an East Asian population (27, 28) .
Increased reporter gene activity in risk allele C of rs933717. The effects of the variant-containing sequences on gene expression were assessed by luciferase reporter assay, in which sequences of 101 bp flanking rs933717 were synthesized and subcloned into minimal promoter-driven firefly luciferase vector pGL4.23 (luc2/minP) reporter vectors and transfected into HEK 293T and Jurkat cells. We observed that the presence of the risk allele C of rs933717 significantly increased luciferase activity from 1.7-fold to 3.8-fold (P = 0.014) in HEK 293T cells and from 1.6-fold to 2.7-fold (P = 0.022) in Jurkat cells ( Figure 3A) .
Differential binding of nuclear extract at rs933717. Evidence of enhancer activity was provided by EMSA; oligonucleotides containing risk allele C of rs933717 showed a greater affinity for nuclear protein-DNA complex with HEK 293T and Jurkat cell nuclear extract than did oligonucleotides containing protective allele T of rs933717 ( Figure 3B ). The nuclear protein-DNA complex was abolished by addition of excessive unlabeled competitor probes ( Figure 3B ). In silico analysis using the JAS-PAR, TransFac, and MAPPER databases predicted binding at the transcription factor binding sites for ROAZ, EBF-1, and ZIC4. However, in the supershift assay, ROAZ-, EBF-1-, and ZIC4-specific antibodies were not observed to supershift the complex formation with either an rs933717 C probe or an rs933717 T probe ( Figure 3B ). In contrast, in the same 2 EMSA experiments performed with HEK 293T cell-and Jurkat cell-derived nuclear samples, the digoxigenin-labeled C probe showed a higher affinity for the nuclear protein-DNA complex ( Figure 3B ). This also indicated that rs933717C differed from rs933717T in formation of the nuclear protein-DNA complex.
Increased autophagy in SLE patients and in lymph nodes of lupus-prone mice. Consistent with the observation that risk alleles are associated with higher levels of gene expression, increased MAP1LC3B expression was also observed in patients with SLE. We used mRNA expression data from a comparatively large project focusing on the gene expression profiling of peripheral blood mononuclear cells (project E-GEOD-20864; ArrayExpress) from 21 SLE patients compared with 45 healthy individuals in a GEO database. That study found significantly elevated levels of MAP1LC3B expression in SLE patients compared to normal controls (P = 1.28 9 10 -9 ) ( Figure 4A ). The result was successfully replicated (in an independent cohort enrolled in our own center) by expression microarray conducted using an Illumina HT-12 v4 Expression BeadChip. Compared with 12 healthy controls, the level of MAP1LC3B expression was significantly higher in 13 SLE patients (P = 2.00 9 10 -2 ) ( Figure 4B ). Using LC3 immunoblotting, autophagy was quantified in lymph nodes obtained from MRL-lpr/lpr lupusprone mice and C57BL healthy control mice. The cellular autophagy response was assessed using LC3B-II normalized to b-actin, the most widely used index. The level of autophagy was significantly higher in lymph nodes from MRL-lpr/lpr mice than in those from healthy control mice (P = 0.013) ( Figure 4C) .
DISCUSSION
In the current study, we conducted various analyses. First, we carried out a gene family-based genetic association analysis involving 26 autophagy-related genes. Although ImmunoChip was designed for dense mapping of immune-related genes instead of autophagy pathway analysis, an increasing number of studies highlighted its power for detecting previously overlooked susceptibility loci (24) . Also, the ImmunoChip design included several rare variants considered to have significant functional effects that might have been previously overlooked.
We observed that rs933717 (MAP1LC3B) was associated, with genome-wide significance, with susceptibility to SLE in >10,000 Chinese individuals. Of special note, rs933717 was found to be associated with susceptibility to ASSOCIATION OF rs933717 WITH SLE IN CHINESEage-related cataracts in a GWAS using 530,101 SNPs from the Illumina Human660W-Quad BeadChip array in a total of 7,397 individuals in an Electronic Medical Records and Genomics Network study. However, the P value was 0.000041, suggesting that a large sample size may be critically necessary. We found data to suggest that the T allele has a protective function, consistent with that previous report (29) . In contrast, expression analysis suggested a likely pathogenic role of increased MAP1LC3B expression in SLE patients, which might be because of an alleledependent effect of risk allele rs933717C. To identify possible molecular mechanisms, functional annotations were performed using ENCODE data, which supported a likely regulatory feature of these variants. To confirm these bioinformatic clues, an in-house functional luciferase reporter assay and an EMSA were carried out. Both supported an enhancer role of the rs933717 region, and LC3B-II levels were higher in lupus-prone mice than in control mice. Taken together, the results from genetic association, expression association, and functional validation tests strongly suggest that MAP1LC3B rs933717 is involved in SLE etiology. Autophagy was increased in patients with systemic lupus erythematosus (SLE) and in lymph nodes from MRL-lpr/lpr mice. A, MAP1LC3B expression was significantly greater in SLE patients according to the GEO data. MAP1LC3B mRNA expression in peripheral blood mononuclear cells (PBMCs) from SLE patients and healthy individuals was analyzed based on project E-GEOD-20864 obtained from ArrayExpress. E-GEOD-20864 is a comparatively large project focusing on gene expression profiling of PBMCs from SLE patients and healthy individuals. B, MAP1LC3B expression was significantly greater in SLE patients in our own cohort. Expression microarray analysis was conducted using an Illumina HT-12 v4 Expression BeadChip in healthy controls and SLE patients. C, Autophagy was significantly greater in lymph nodes from MRL-lpr/ lpr mice. Bottom, Blots shown are representative of independent experiments performed in 10 C57BL mice and 10 MRL-lpr/lpr mice. Top, Scatterplot shows results of densitometry of light chain 3B-II (LC3B-II) levels relative to ACTB/b-actin. Symbols represent individual subjects (A and B) or mice (C); bars show the mean AE SEM (A and B) or the median and interquartile range (C). Levels of LC3B-II were significantly greater in lymph nodes from MRL-lpr/lpr mice than in those from C57BL control mice.
294
QI ET AL Microtubule-associated protein LC3B is encoded by the MAP1LC3B gene. LC3B is a central protein in autophagy since it is involved in cargo recruitment into autophagosomes and in biogenesis and maturation of autophagosomes. More importantly, LC3B is the most widely used autophagosome marker (30) . In the present study, expression analysis suggested a likely pathogenic role of increased LC3B in SLE patients. Further experiments also showed that LC3B levels were higher in lupusprone mice than in healthy control mice, corroborating the current observation that higher levels of LC3B were consistently observed in lupus-prone mouse models and SLE patients (5-7). Following these observations, it was further suggested that autophagy is genetically associated with SLE. Our data suggested that rs933717 of MAP1LC3B could increase the expression of LC3B in immune cells by both cis-and trans-eQTL effects. Genetic association, expression association, and functional validation highlight the likely important role of rs933717 in Chinese SLE patients. However, the associations were not able to determine whether rs933717 was the single causal variant or whether it was just in linkage disequilibrium with a nearby variant. Thus, further fine-mapping analysis is needed.
SLE is an autoimmune disease and is characterized as an abnormality of the immune system that includes antigen presentation by antigen-presenting cells as well as the survival of autoreactive T and B cells that leads to the production of large amounts of autoantibodies. Recent studies indicated that autophagy was involved in the presentation of intracellular antigens to major histocompatibility complex (MHC) class II molecules (31, 32) . Higher rates of autophagy led to a more active MHC presentation process, which might lead to the breakdown of immune tolerance and an increase of the immune response. In addition, increased autophagy would promote the survival of autoimmune T and B cells, which in turn would lead to high levels of autoantibody and cytokine production and multiple organ/system involvement (33) (34) (35) (36) (37) (38) (39) (40) . Thus, high levels of autophagy might promote the initiation of autoimmunity in SLE by influencing multiple aspects of the immune system. More importantly, it was recently reported that LC3-associated phagocytosis controls immune responses to dying cells and that its inhibition leads to the development of SLElike disease (9) . Our data reinforced the notion that LC3 might be genetically involved in SLE (9) .
We included SNP mapping to autophagy-related genes along with regions 20 kb upstream and downstream. Although rs933717 was annotated to be an intronic variant of FBXO31, its associated regulatory SNP-related genes included MAP1LC3B (proximal transcriptional regulation) and FBXO31 (distal transcriptional regulation and RNA binding protein-mediated regulation) (Ensembl [http:// asia.ensembl.org/index.html] and rSNPBase [http://rsnp. psych.ac.cn/]). It is difficult to determine the exact causal variant and gene in this type of strategy of forward genetic association. In most cases, GWAS implicated disease susceptibility loci rather than directly identifying disease-associated genes. This is because many of the disease-associated SNPs were located in an intergenic region with the susceptibility gene, or the functional locus was located within a region near the SNP, which often contained multiple genes. We thus also analyzed the differential expression of FBXO31 between SLE patients and healthy controls using data from GEO and from our own cohort. We found no significant difference in expression of FBXO31 (P = 0.092 for data from GEO accession no. GSE20864; P = 0.343 for data from our center). Thus, rs933717 was more likely to be involved in the pathogenesis of SLE by influencing MAP1LC3B. F-box proteins, in conjunction with Skp1, Cul1, and Rbx1, generate F-box containing complex (or SCF complex) that is responsible for the ubiquitination of proteins, leading to their activation or degradation. The F-box protein FBXO31 is required for normal mitotic progression and genome stability due to its role in regulating FOXM1 levels during the G 2 /M transition. Therefore, future study targeting FBXO31 is also of interest.
Genetic associations between autophagy gene variants were pronounced in Asian populations, as most autophagy genetic associations could be replicated in our previous studies (2, 13, 14, 20) . However, few of these genetic associations were reported in Caucasians or Africans, suggesting genetic heterogeneity and that the autophagy gene has a major impact in Asian populations (18, 21) . The rs933717 variant is seen in Asians but is more common in Caucasians, which might be because of natural selection. However, the mechanisms by which this kind of natural selection affects autophagy and SLE epidemiology need to be further investigated, including independent replications observed in other populations (24) .
In the current study, differential effects of nuclear protein binding with the rs933717 C/T allele were observed, which may support the notion that rs933717 influences the expression of MAP1LC3B. However, the exact transcription factor was not clearly determined, as it was not validated by anti-ROAZ or anti-EBF-1 antibodyspecific supershift assay. Further exploration to seek the binding factor, such as chromatin immunoprecipitation and promoter microarray analysis or ChIP-Seq, or in other cell lines, is still warranted.
In summary, we systemically evaluated genes involved in autophagy in a large sample using a 4-stage strategy, including genetic discovery, genetic replication, bioinformatic analysis, and experimental validation. We observed likely novel genetic associations between LC3B (encoded by MAP1LC3B), an excellent marker for autophagic structures, and susceptibility to SLE. Our work was committed to providing a more complete understanding of SLE pathogenesis, especially focusing on autophagy. A deeper knowledge of the relationship between autophagy and SLE is likely to lead to the discovery of new therapeutic targets.
